Autoimmune phenotypes in schizophrenia reveal novel treatment targets

Typical and atypical antipsychotics are the first-line treatments for schizophrenia, but these classes of drugs are not universally effective, and they can have serious side effects that impact compliance. Antipsychotic drugs generally target the dopamine pathways with some variation. As research of...

Descripción completa

Detalles Bibliográficos
Autores principales: Severance, Emily G., Dickerson, Faith B., Yolken, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097895/
https://www.ncbi.nlm.nih.gov/pubmed/29742478
http://dx.doi.org/10.1016/j.pharmthera.2018.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097895/
https://www.ncbi.nlm.nih.gov/pubmed/29742478
http://dx.doi.org/10.1016/j.pharmthera.2018.05.005

Ejemplares similares